We've moved! Same resources, new address:

Find resources

Total results with these characteristics: 175

Disease: Human papillomavirus (HPV)

Page 6 of 9
Knowledge of Cervical Cancer and HPV Vaccine Post-Vaccination Among Mothers and Daughters in Vietnam

The authors of this article, published in the Asian Pacific Journal of Cancer Prevention, assessed and compared knowledge and attitudes about cervical cancer and human papillomavirus (HPV) vaccines, and whether that knowledge was associated with …

Author: Paul P, LaMontagne DS, Le NT

Publication date: 2012

Landscape Analysis: Trends in Vaccine Availability and Novel Vaccine Delivery Technologies: 2008–2025

This landscape analysis identifies trends in the availability of vaccines and novel vaccine delivery technologies that are and will be of relevance to low- and middle-income countries from the present through 2025.

Author: PATH, World Health Organization

Publication date: 2008

Lessons Learned From HPV Vaccine Delivery in Low-Resource Settings and Opportunities for HIV Prevention, Treatment, and Care Among Adolescents

This article, published in the Journal of Acquired Immune Deficiency Syndromes, identifies key lessons learned from human papillomavirus (HPV) vaccine introduction in low- and middle-income countries that could be used to amplify current and future …

Author: Tsu V, Cernuschi T, LaMontagne DS

Publication date: 2014

Lessons Learnt From Human Papillomavirus (HPV) Vaccination in 45 Low- and Middle-Income Countries

This article, published in PLoS ONE, synthesizes lessons learned and determinants of success from human papillomavirus (HPV) vaccine demonstration projects and national programs in low- and middle-income countries (LMICs). The authors conducted …

Author: Gallagher KE, Howard N, Kabakama S, et al.

Publication date: 2017

Managing HPV: Health Care Team Tool Kit

This web page provides a tool kit to increase the awareness and knowledge of health care providers, frontline staff, business personnel, and educators about human papillomavirus (HPV), cervical cancer screening, the treatment of genital warts, and …

Author: Association of Reproductive Health Professionals

Manufacturing Costs of HPV Vaccines for Developing Countries

This article, published in Vaccine, details an analysis designed to estimate the manufacturing costs (including annualized capital costs, vaccine yield, raw materials, manufacturing personnel, factory/administrative overheads, and filling/packaging) …

Author: Clendinen C, Zhang Y, Warburton RN, Light DW

Publication date: 2016

Monitoring Ambient and Cold Chain Temperatures During Delivery of Human Papillomavirus Vaccine in Vietnam and Uganda: Summary Report

This report summarizes the design and key findings of temperature monitoring studies that gathered ambient temperature data during different HPV vaccine delivery strategies and in multiple geographic settings and seasons.

Author: PATH

Publication date: 2010

Monitoring Ambient Temperatures Experienced During Delivery of Human Papillomavirus Vaccine in Uganda

This report discusses a five-year human papillomavirus (HPV) vaccine demonstration project in Uganda that aims to demonstrate how existing health systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a …

Author: PATH, World Health Organization

Publication date: 2010

National HPV and Cervical Cancer Prevention Resource Center

This resource center was created to address the lack of nationally available human papillomavirus (HPV) and cervical cancer prevention information and resources. The center is dedicated to addressing the multiple issues and challenges associated …

Author: American Social Health Association

New Guidelines for the Screening and Treatment of Cervical Cancer

This web page provides information on the World Health Organization's guidelines on screening and treating cervical cancer and links to various related resources, including data on cervical cancer incidence and mortality worldwide and a fact sheet …

Author: World Health Organization

New Options for Cervical Cancer Screening and Treatment in Low-Resource Settings

This issue brief examines screening in the era of HPV vaccination and provides the latest evidence on new screening and treatment modalities for developing countries. It summarizes the current evidence on various options, namely cervical cytology …

Author: Cervical Cancer Action

Obstacles to Vaccines for AIDS, Tuberculosis, and Cervical Cancer

Despite advances in prevention and treatment, AIDS, tuberculosis, and cervical cancer remain among the most serious and costly threats to world health. This article, published by the Population Reference Bureau, outlines the potential impact of …

Author: Khan M

Publication date: 2006

PATH Supports Global HPV Vaccine Introduction

This fact sheet outlines PATH's role in providing technical assistance to countries for the planning, implementation, and evaluation of human papillomavirus (HPV) vaccination programs. The PATH HPV vaccine team’s activities are channeled through …

Author: PATH

Publication date: 2014

Paving Pathways: Brazil’s Implementation of a National Human Papillomavirus Immunization Campaign

This article, published in Revista Panamericana de Salud Pública, examines factors that may influence the long-term success of Brazil’s human papillomavirus (HPV) vaccination program—sustaining effective outreach, managing a large …

Author: Baker ML, Figueroa-Downing D, De Oliveira Chiang ED, et al.

Publication date: 2015

Performance of 21 HPV Vaccination Programs Implemented in Low and Middle-Income Countries, 2009–2013

This study, published in BMC Public Health, examined 21 human papillomavirus (HPV) vaccination programs in 14 low- and middle- income countries. School and health clinic-based models appeared as predictive factors for vaccination coverage, as was …

Author: Ladner J, Besson M-H, Rodrigues M, Audureau E, Saba J

Publication date: 2014

Persistence of Immune Responses to the HPV-16/18 AS04-Adjuvanted Vaccine in Women Aged 15-55 Years and First-Time Modelling of Antibody Responses in Mature Women: Results From an Open-Label 6-Year Follow-Up Study

This article, published in BJOG: An International Journal of Obstetrics & Gynaecology, reports on a study to evaluate the HPV-16/18 AS04-adjuvanted vaccine's long-time immunogenicity persistence in women. The authors found that six years after …

Author: Schwarz T, Spaczynski M, Kaufmann A, et al.

Publication date: 2015

The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases

This book provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on vaccine-preventable diseases. In addition to chapters on more general vaccine-related topics, it …

Author: US Centers for Disease Control and Prevention

Publication date: 2015

Population-Level Impact and Herd Effects Following Human Papillomavirus Vaccination Programmes: A Systematic Review and Meta-Analysis

This article, published in The Lancet Infectious Diseases, reports on a study to assess the population-level consequences of female human papillomavirus (HPV) vaccination programs to verify if the high efficacy reported in randomized controlled …

Author: Drolet M, Bénard E, Boily M-C, et al.

Publication date: 2015

Potential Impact of a 9-valent HPV Vaccine in HPV-Related Cervical Disease in 4 Emerging Countries (Brazil, Mexico, India and China)

This article, published in Cancer Epidemiology, reports on a study that estimated the potential impact of an investigational 9-valent human papillomavirus (HPV) vaccine (HPVs 6/11/16/18/31/33/45/52/58) on HPV-related cervical disease in Brazil, …

Author: Serrano B, Alemany L, de Ruiz PA, et al.

Publication date: 2014

Present Status of Human Papillomavirus Vaccine Development and Implementation

This article, published in The Lancet Oncology, provides an overview of the current human papillomavirus (HPV) vaccines available, vaccine efficacy and safety, current HPV recommendations, and vaccine introduction into national health …

Author: Herrero R, Gonzalez P, Markowitz LE

Publication date: 2015

Page 6 of 9